NIH-funded research R21 grant

Investigating how certain enzymes affect recovery from brain injuries and dementia.

Official title: Pharmacological inhibition of NEP-like enzymes in traumatic brain injury and dementia

Funded at Rosalind Franklin Univ of Medicine & Sci · NIH-11088216 · Data updated 2026-11-12

This study is looking at how certain enzymes might help the brain heal after a traumatic brain injury and how they could be connected to dementia, with the hope that what we learn could lead to better treatments for both conditions.

More Dementia research and trials

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionRosalind Franklin Univ of Medicine & Sci
NIH-funded
Lab location1 site (North Chicago, United States)
Project startMay 15, 2024
Project endApril 30, 2026
Funding year2025
Award (this year)$197,375
NIH project number5R21NS130331-02
Project IDNIH-11088216 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals who have experienced a traumatic brain injury or are at risk for dementia.

Less likely to help

Patients with conditions unrelated to traumatic brain injury or dementia may not receive any benefit from this research.

What this research studies

This research explores the role of NEP-like enzymes in the recovery process following traumatic brain injury (TBI) and their potential link to the development of dementia. By using humanized transgenic mice, the study will manipulate the activity of these enzymes to assess their impact on amyloid-beta peptide levels, which are crucial for brain health. The research aims to understand both the immediate and long-term effects of these enzymes on brain recovery and dementia risk. Patients may benefit from insights that could lead to new treatments for TBI and dementia.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic strategies for improving recovery from traumatic brain injuries and reducing the risk of developing dementia.

How similar studies have gone: Other research has shown promising results in understanding the role of amyloid-beta clearance in brain injuries, suggesting that this approach may yield valuable insights.

Where this research is happening

  • Rosalind Franklin Univ of Medicine & Sci
    North Chicago, United States
    Active

Researchers

  • Principal investigator: Marr, Robert Anthony — Rosalind Franklin Univ of Medicine & Sci
  • Study coordinator: Marr, Robert Anthony

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.